Flow Cytometry: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
<span style="color:navy> | <span style="color:navy>''Markers used mainly for gating:''</span> | ||
{|style="width: 80px; height: 80px; text-align:center; font-style: bold; font-size: 120%; color: navy; background: #EEEFF7; border-style: solid; border-width: 2px" | {|style="width: 80px; height: 80px; text-align:center; font-style: bold; font-size: 120%; color: navy; background: #EEEFF7; border-style: solid; border-width: 2px" | ||
Line 13: | Line 12: | ||
<span style="color:navy> | <span style="color:navy>''Non CD-classified markers''</span> | ||
{|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px" | {|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px" | ||
Line 24: | Line 22: | ||
'''[[Immunoglobulin light chains|<span style="color:maroon">'''lambda'''</span>]]''' | '''[[Immunoglobulin light chains|<span style="color:maroon">'''lambda'''</span>]]''' | ||
|} | |} | ||
{|style="float:left; width: | {|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px" | ||
| | | | ||
'''[[FMC7]]''' | '''[[FMC7|<span style="color:maroon">'''FMC7'''</span>]]''' | ||
|} | |} | ||
{|style="float:left; width: | {|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px" | ||
| | | | ||
'''[[TDT]]''' | '''[[TDT|<span style="color:maroon">'''TDT'''</span>]]''' | ||
|} | |} | ||
{|style="float:left; width: | {|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px" | ||
| | | | ||
'''[[MPO]]''' | '''[[MPO|<span style="color:maroon">'''MPO'''</span>]]''' | ||
|} | |} | ||
{|style="float:left; width: | {|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: maroon; background: #faeed8; border-style: solid; border-width: 2px; margin: 5px" | ||
| | | | ||
'''[[IgM]]''' | '''[[IgM|<span style="color:maroon">'''IgM'''</span>]]''' | ||
|} | |} | ||
Line 47: | Line 45: | ||
3. '''CD-classified markers frequently used in leukaemia diagnosis''' | 3. '''CD-classified markers frequently used in leukaemia diagnosis''' | ||
{|style="float:left; width: | {|style="float:left; width: 80px; height: 80px; text-align:center; font-style: bold; color: #0b7514; background: #ecf4e4; border-style: solid; border-width: 2px; margin: 5px" | ||
| | | | ||
'''[[CD2]]''' | '''[[CD2|<span style="color:#0b7514">'''CD2'''</span>]]''' | ||
|} | |} | ||
{|style="float:left; width: 100px; height: 100px; text-align:center; font-style: bold; color: teal; border-style: solid; border-width: 15px; margin: 5px" | {|style="float:left; width: 100px; height: 100px; text-align:center; font-style: bold; color: teal; border-style: solid; border-width: 15px; margin: 5px" | ||
| | | | ||
'''[[CD3]]''' | '''[[CD3|<span style="color:maroon">'''CD3'''</span>]]''' | ||
|} | |} | ||
{|style="float:left; width: 100px; height: 100px; text-align:center; font-style: bold; color: teal; border-style: solid; border-width: 15px; margin: 5px" | {|style="float:left; width: 100px; height: 100px; text-align:center; font-style: bold; color: teal; border-style: solid; border-width: 15px; margin: 5px" |